Your browser is no longer supported. Please, upgrade your browser.
Perrigo Company Public Limited Company
IndexS&P 500 P/E60.11 EPS (ttm)2.57 Insider Own0.10% Shs Outstand140.78M Perf Week2.13%
Market Cap21.75B Forward P/E18.30 EPS next Y8.44 Insider Trans-6.16% Shs Float140.07M Perf Month0.71%
Income346.50M PEG4.54 EPS next Q1.78 Inst Own79.90% Short Float1.53% Perf Quarter-1.20%
Sales4.17B P/S5.21 EPS this Y-62.00% Inst Trans10.17% Short Ratio2.31 Perf Half Y3.95%
Book/sh71.28 P/B2.17 EPS next Y15.09% ROA2.40% Target Price180.64 Perf Year-6.85%
Cash/sh25.69 P/C6.01 EPS next 5Y13.23% ROE3.90% 52W Range124.99 - 171.86 Perf YTD-7.51%
Dividend0.50 P/FCF29.31 EPS past 5Y3.10% ROI2.80% 52W High-10.12% Beta0.38
Dividend %0.32% Quick Ratio3.60 Sales past 5Y15.20% Gross Margin34.40% 52W Low23.58% ATR2.75
Employees10220 Current Ratio4.00 Sales Q/Q-44.00% Oper. Margin15.70% RSI (14)50.29 Volatility1.45% 1.81%
OptionableYes Debt/Eq0.49 EPS Q/Q96.20% Profit Margin8.30% Rel Volume1.41 Prev Close155.25
ShortableYes LT Debt/Eq0.46 EarningsFeb 05 BMO Payout16.20% Avg Volume929.37K Price154.47
Recom1.80 SMA201.95% SMA50-2.40% SMA2002.31% Volume1,310,431 Change-0.50%
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
Nov-07-14Reiterated RBC Capital Mkts Outperform $169 → $177
Sep-22-14Reiterated RBC Capital Mkts Outperform $160 → $169
May-15-14Reiterated Argus Buy $175 → $160
May-08-14Reiterated B. Riley & Co. Neutral $170 → $157
May-08-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
Mar-03-14Reiterated UBS Buy $176 → $190
Mar-03-14Reiterated Stifel Buy $165 → $175
Feb-25-14Reiterated CRT Capital Buy $165 → $175
Feb-07-14Downgrade B. Riley & Co. Buy → Neutral
Jan-16-14Reiterated Argus Buy $160 → $175
Jan-07-14Initiated RBC Capital Mkts Top Pick $187
Dec-12-13Reiterated Stifel Buy $150 → $165
Nov-07-13Reiterated Argus Buy $152 → $160
Nov-04-13Reiterated UBS Buy $140 → $160
Oct-21-13Initiated Argus Buy $152
Sep-17-13Initiated CRT Capital Buy $145
Jul-30-13Reiterated B. Riley & Co. Buy $139 → $145
Jul-09-13Reiterated Canaccord Genuity Buy $128 → $140
Feb-26-15 09:30AM  Israel ETFs in Focus on Surprise Rate Cut - ETF News And Commentary Zacks
Feb-20-15 06:00PM  CEOs to Cramer: This is how we win CNBC
06:00AM  Jim Cramer's Top Stock Picks: TMUS SBUX EOG JACK PRGO WMT at TheStreet
Feb-19-15 07:56PM  Jim Cramer's 'Mad Money' Recap: 8 CEOs I Want on My All-Star Team at TheStreet
07:03PM  Cramer Remix: Avoid this at all costs at CNBC
Feb-17-15 08:01AM  Perrigo Company To Present At The 2015 RBC Global Healthcare Conference PR Newswire
Feb-10-15 09:31AM  Moody's: Large healthcare acquirers will show different rates of deleveraging in 2015 at Moody's
Feb-06-15 11:11AM  Three Reasons To Let Akorn Fall Into Your Portfolio at Investor's Business Daily
09:08AM  Perrigo Co (PRGO) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
07:00AM  Perrigo Company plc (PRGO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-05-15 05:33PM  Generic-Drug Makers Soar, And It's Easy To See Why at Investor's Business Daily
05:03PM  Stocks Rise In Weak Trade; LinkedIn Jumps After Hours at Investor's Business Daily
04:18PM  Stocks Close Near Session Highs, But Volume Softens at Investor's Business Daily
10:15AM  Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog Zacks
08:46AM  Perrigo (PRGO) Beats on Q4 Earnings, Revenues In Line - Tale of the Tape Zacks
07:29AM  Perrigo Company plc Reports Record Second Quarter Revenue, Adjusted Net Income And Adjusted Margins PR Newswire
07:07AM  Q2 2015 Perrigo Company PLC Earnings Release - Before Market Open CCBN
Feb-03-15 04:05PM  Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog Zacks
Jan-29-15 05:30PM  Galmed, Perrigo Tie Up for Mass Production of Aramchol API - Analyst Blog Zacks
08:16AM  Perrigo Company plc To Release Second Quarter Fiscal Year 2015 Results On February 5, 2015 - Updating Call Time PR Newswire
Jan-28-15 08:00AM  Galmed and Perrigo Execute Manufacturing Agreement for Large-Scale Aramchol API Production PR Newswire
Jan-27-15 07:43AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Jan-22-15 08:17AM  Perrigo Company plc To Release Second Quarter Fiscal Year 2015 Results On February 5, 2015 PR Newswire
Jan-20-15 07:05PM  Cramer Remix: Netflix after the big news at CNBC
Jan-15-15 06:16AM  Perrigo trader looking for breakout optionMONSTER
Jan-14-15 11:39AM  Notable option trades in equities optionMONSTER
Jan-12-15 08:27AM  Perrigo Launches AB Therapeutic Equivalent Testosterone Gel 1.0% PR Newswire
08:24AM  Perrigo Partners With Ferrara Candy Company To Enter $625 Million Gummy Vitamins And Dietary Supplement Market PR Newswire
08:22AM  Perrigo Launches The Generic Version Of Clobex® (Clobetasol Propionate) Spray, 0.05% PR Newswire
Jan-06-15 11:16AM  Perrigo Company To Present At The 33rd Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-19-14 01:27PM  Stocks Off Highs But Stay Positive; Nike Drags Dow at Investor's Business Daily
Dec-02-14 01:31PM  Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Senior Notes PR Newswire
08:48AM  Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w PR Newswire
Nov-26-14 11:51AM  Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares PR Newswire
Nov-24-14 04:42PM  Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc PR Newswire
11:17AM  Animal-Health Picks That Won't Be Cowed at
08:48AM  Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering PR Newswire
08:47AM  Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc PR Newswire
07:54AM  Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed® (Testosterone Undecanoate) Injection PR Newswire
07:52AM  Perrigo Announces The Launch Of A Generic Version Of Astellas' Protopic® Ointment 0.1% And 0.03% PR Newswire
Nov-20-14 08:05PM  Perrigo Company plc Announces the Pricing of its Offering of Ordinary Shares PR Newswire
12:15PM  Perrigo (PRGO) Is Today's Unusual Social Activity Stock at TheStreet
07:35AM  Perrigo to Sell Stock to Fund Omega Deal at The Wall Street Journal
06:49AM  Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares PR Newswire
Nov-12-14 02:47PM  SAC's Martoma loses bid for bail during insider trading appeal Reuters
Nov-06-14 06:49PM  Perrigo to buy Omega Pharma Investor's Business Daily
04:39PM  Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
03:11PM  Perrigo joins wave of OTC drug deals at Financial Times
11:28AM  Perrigo Acquires Omega Pharma For $4.5 Billion Euro Benzinga
10:38AM  Perrigo to buy Omega Pharma for $4.5 billion at MarketWatch
10:12AM  Perrigo (PRGO) Is Today's Water-Logged And Getting Wetter Stock at TheStreet
10:10AM  Perrigo Misses on Earnings and Sales, Maintains Guidance Zacks
10:08AM  [$$] Perrigo in $4.5 Billion Deal for Rival at The Wall Street Journal
08:51AM  Perrigo to buy Omega Pharma in $3.1-billion deal AP
07:07AM  Q1 2015 Perrigo Company PLC Earnings Release - Before Market Open CCBN
06:49AM  Perrigo to buy Belgium's Omega Pharma for $3.11 bln Reuters
06:43AM  Perrigo to Buy Omega Pharma of Belgium for $4.5 Billion at Bloomberg
06:39AM  Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets PR Newswire
06:32AM  Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins PR Newswire
06:26AM  Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company PR Newswire
Nov-04-14 06:23PM  SAC's Martoma wins delay of 9-year insider trading prison term Reuters
03:45PM  Will Perrigo (PRGO) Disappoint This Earnings Season? Zacks
Nov-03-14 03:12PM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Oct-30-14 12:03PM  U.S. SEC wants to distribute $602 mln SAC settlement to victims Reuters
09:19AM  Perrigo Said in Exclusive Talks to Acquire Omega Pharma at Bloomberg
Oct-28-14 01:00PM  Bridgewater Associates sold its position in Perrigo Co. Market Realist
09:00AM  Why Bridgewater starts new position in Bed, Bath and Beyond Market Realist
Oct-27-14 05:59PM  Lannett Co. Gets Growth Rx In Generic Drugs Group at Investor's Business Daily
12:34PM  Overview: Bridgewater Associates new positions in 2Q14 Market Realist
Oct-23-14 08:34AM  Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014 PR Newswire
Oct-22-14 10:10AM  Boehringer Ingelheim says not interested in buying Omega Pharma Reuters
Oct-20-14 06:08PM  Actavis, Sanofi among bidders for Omega Pharma - Bloomberg Reuters
05:14PM  Actavis Said to Compete With Sanofi for Omega Pharma Deal at Bloomberg
Oct-15-14 04:33PM  Wife of convicted ex-SAC employee petitions to keep cash, home Reuters
Oct-14-14 10:25AM  Perrigo Animal Health Receives SQF Certification PR Newswire
Oct-10-14 05:37PM  Inversion Vitriol Vs. Drug Consolidation Investor's Business Daily
Oct-06-14 06:08PM  Generics Firms Step Up Their Game In Branded Drugs at Investor's Business Daily
Oct-03-14 06:03PM  U.S. SEC to decide if investors share in $600 mln SAC settlement Reuters
03:45PM  Perrigo Sells Some Assets to Imago Pharmaceuticals Zacks
Oct-02-14 08:48AM  Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 PR Newswire
Oct-01-14 08:53AM  Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 PR Newswire
Sep-30-14 04:10PM  AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio Zacks
Sep-29-14 12:09PM  Akorn Upgraded On Strong Generic Drug Trends at Investor's Business Daily
11:13AM  Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B at TheStreet
08:31AM  Lumara Health to sell assets to AMAG, Perrigo for $757 million at MarketWatch
07:39AM  Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals PR Newswire
07:15AM  Lumara Health to be Acquired in Two Separate Transactions for up to $1.107 Billion PR Newswire
07:08AM  Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health PR Newswire
Sep-26-14 06:07PM  Multiple Sclerosis Drugs Could Transform Market Again at Investor's Business Daily
Sep-10-14 07:38AM  #PreMarket Primer: Wednesday, September 10: Dollar General Gets Aggressive Benzinga
04:17AM  S&P: Inversions Could Lead to Credit Downgrades at The Wall Street Journal
Sep-08-14 06:21PM  SAC's Martoma gets 9 years prison for insider trading Reuters
04:47PM  SAC's Martoma gets 9 years prison for record insider trading scheme Reuters
Sep-04-14 02:01PM  U.S. judge won't toss insider trading conviction of SAC's Martoma Reuters
Aug-26-14 08:25PM  Jim Cramer's 'Mad Money' Recap: A Monster of an August at TheStreet
06:24PM  Despite new highs, Cramer spots a bargain stock at CNBC
Aug-22-14 10:00AM  3 Imperfect Ways To Lower Corporate Taxes And Increase American Jobs at Forbes
Aug-14-14 06:36PM  Perrigo Regains Some Lost Ground On Fiscal Q4 Beat at Investor's Business Daily +7.28%
04:43PM  [video] U.S. Markets Close Higher, Red Robbin Serves Disappointing Earnings at TheStreet
04:37PM  Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving Benzinga
Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company's Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company's API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farrington ThomasSenior VP and CIOFeb 20Sale151.1851778,161321Feb 24 04:26 PM
Farrington ThomasSenior VP and CIOFeb 06Option Exercise0.0079801,119Feb 09 04:37 PM
MORRIS HERMAN JRDirectorNov 14Sale154.4220030,8831,400Nov 17 05:22 PM
Kochan SharonEVP, GM InternationalNov 10Option Exercise90.655,367486,51910,767Nov 12 04:37 PM
Kochan SharonEVP, GM InternationalNov 10Sale156.365,367839,1845,400Nov 12 04:37 PM
Yu LouisExecutive VP Global QualityNov 10Sale155.1125940,1734,886Nov 12 04:33 PM
Brown Judy LExecutive VP & CFONov 03Option Exercise48.923,515171,9539,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFONov 03Sale160.603,515564,5077,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFOOct 01Option Exercise48.923,515171,9539,445Oct 02 04:26 PM
Brown Judy LExecutive VP & CFOOct 01Sale150.723,515529,7817,445Oct 02 04:26 PM
KINGMA TODD WExecutive VP, General CounselSep 03Sale150.101,000150,0952,000Sep 03 05:00 PM
Kochan SharonEVP, GM InternationalSep 03Sale150.001,116167,4005,400Sep 04 04:42 PM
Farrington ThomasSenior VP and CIOSep 02Sale150.361,741261,773321Sep 03 05:12 PM
KINGMA TODD WExecutive VP, General CounselAug 29Option Exercise35.851,25044,81310,614Sep 03 05:00 PM
KINGMA TODD WExecutive VP, General CounselAug 29Sale149.301,250186,6259,364Sep 03 05:00 PM